Relief Therapeutics Holding SA

BATS-CHIXE:RLFZ Stock Report

Market Cap: CHF 48.3m

Relief Therapeutics Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RLFZ?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders87,5080.698%
Institutions1,449,76511.6%
VC/PE Firms2,889,74723%
General Public8,113,41964.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 18 shareholders own 35.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23%
Global Emerging Markets
2,889,747CHF 11.1m0%77.2%
8.96%
Goldman Sachs Group, Investment Banking and Securities Investments
1,123,144CHF 4.3m0%no data
1.89%
UBS Asset Management AG
237,110CHF 912.9k31.8%no data
0.62%
Paolo Galfetti
78,093CHF 300.7k0%no data
0.2%
ZKB Asset Management
25,363CHF 97.6k0%no data
0.19%
Zürcher Kantonalbank, Investment Arm
23,891CHF 92.0k0%no data
0.17%
Pictet Asset Management SA
21,075CHF 81.1k0%no data
0.059%
Lombard Odier Asset Management (Switzerland) SA
7,460CHF 28.7k0%no data
0.056%
Peter de Svastich
7,001CHF 27.0k0%no data
0.05%
BlackRock, Inc.
6,257CHF 24.1k0%no data
0.03%
British & American Investment Trust PLC
3,785CHF 14.6k0%0.23%
0.013%
Dimensional Fund Advisors LP
1,591CHF 6.1k0%no data
0.01%
Thomas Plitz
1,250CHF 4.8k0%no data
0.0037%
Jack Weinstein
463CHF 1.8k0%no data
0.0028%
Jeremy Meinen
351CHF 1.4k0%no data
0.0028%
Patrice Jean
350CHF 1.3k0%no data
0.00061%
Horizon Financial Services, LLC
77CHF 294.50%no data
0.0001%
Strategic Investment Solutions, Inc.
12CHF 48.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 01:49
End of Day Share Price 2025/01/09 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Relief Therapeutics Holding SA is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexandre MüllerResearch Dynamics
Bob PoolerValuationLAB AG